Friday 23 October 2026
Export PCSA’s income statement to Excel — free account
Heatwurx Inc.
PCSA Healthcare Biotechnology
In the quarter to June 2026, EPS grew 81.0% and free cash flow grew 20.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.88
0.02
+1.08%
Follow PCSA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
23.92 | 1.14 | 3.13 | 0.85 | 13.27 | 18.87 | 8.40 | 7.71 | 1.23 | 2.54 |
Net Debt/EBITDA |
1.09 | 0.22 | 0.33 | (0.08) | 1.07 | 1.45 | 0.34 | 0.41 | 0.10 | 0.40 |
Debt/Assets |
0.00% | 82.09% | 1.84% | 8.73% | 0.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 6.56 | 0.02 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
1.12 | 0.89 | 0.98 | 0.71 | 0.22 | 0.76 | 0.35 | 0.73 | 0.95 | 0.84 |
Capex/Depreciation |
(17.00) | (0.82) | (2.65) | 0.00 | 0.00 | 0.00 | 0.00 | (14.00) | (4.00) | (708.33) |
Interest Coverage |
(427.00) | (30.50) | (28.07) | (107.23) | (53.85) | (1,011.12) | (200.17) | — | — | — |
| (1,329.47%) | (140.61%) | (74.75%) | (43.64%) | (93.14%) | (47.20%) | (166.43%) | (178.52%) | (354.51%) | (372.96%) | |
| (155.28%) | (69.42%) | (48.69%) | (33.08%) | (79.86%) | (44.23%) | (156.34%) | (154.40%) | (262.87%) | (245.66%) | |
ROIC |
(682.35%) | 0.00% | (34.53%) | (29.74%) | (125.00%) | (84.38%) | (1,309.15%) | (2,530.28%) | (1,491.78%) | (21,694.32%) |
Return on Tangible Assets |
(84.76%) | (491.60%) | (270.45%) | 2,200.97% | (96.21%) | (65.56%) | (360.10%) | (226.76%) | (3,370.34%) | (394.48%) |
Average Days of Receivables |
— | 0.00 | 0.00 | — | 0.00 | 0.00 | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.84 | 0.89 | 0.35 | 0.30 | 0.00 | 0.00 | 0.00 | 0.15 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(259.38) | (180.13) | (348.62) | (247.76) | (209.55) | (284.88) | (298.29) | (153.64) | (91.90) | (9.35) |
Cash per Share |
248.95 | 306.17 | 162.71 | 62.30 | 1,027.75 | 539.14 | 201.98 | 89.64 | 9.73 | 4.23 |
Shareholders Equity per Share |
269.90 | 40.13 | 906.64 | 721.86 | 1,529.30 | 832.85 | 232.01 | 95.03 | 13.86 | 4.26 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
269.90 | 40.13 | 906.64 | 721.86 | 1,529.30 | 832.85 | 232.01 | 95.03 | 13.86 | 4.26 |
Free Cash Flow |
(2.18) | (1.68) | (3.73) | (2.75) | (3.14) | (8.72) | (9.61) | (8.07) | (11.25) | (12.24) |
Working Capital |
2.24 | 0.35 | 1.37 | (0.18) | 14.98 | 17.36 | 7.39 | 4.90 | 0.35 | 3.43 |
Capital Expenditures |
(0.02) | (0.02) | (0.02) | — | — | — | — | 0.00 | 0.00 | (0.85) |
Net Current Asset Value |
2.24 | 0.34 | (0.76) | (1.86) | 13.93 | 17.35 | 7.24 | 4.84 | 0.35 | 3.43 |
| Other line items | ||||||||||
Quick Ratio |
21.40 | 1.12 | 2.73 | 0.58 | 12.69 | 17.06 | 6.51 | 6.44 | 0.78 | 2.48 |
Depreciation/Fixed assets |
0.06 | 0.98 | 0.48 | 90.52 | 1,607.60 | 10.66 | 3.97 | 0.08 | 0.16 | 0.32 |
Cash ROIC |
(49.99%) | (29.55%) | (31.96%) | (28.49%) | (8.19%) | (20.76%) | (68.73%) | (83.20%) | (389.55%) | (110.09%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | — | 0.00 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(256.55) | (177.91) | (346.53) | (247.76) | (209.55) | (284.88) | (298.29) | (153.59) | (91.87) | (8.70) |
Capex per Share |
(2.83) | (2.22) | (2.08) | 0.00 | 0.00 | 0.00 | 0.00 | (0.05) | (0.03) | (0.65) |
Average Receivables |
— | 0.03 | 0.04 | — | 0.05 | 0.07 | — | — | — | — |
Average Payables |
0.09 | 0.03 | 0.17 | 0.18 | 0.20 | 0.27 | 0.27 | 0.32 | 0.60 | 0.97 |
Average Inventory |
0.00 | 0.00 | — | — | — | — | — | — | — | — |
Average Assets |
1.23 | 2.67 | 7.73 | 11.68 | 18.05 | 25.84 | 17.54 | 7.20 | 4.51 | 5.52 |
Average Common Equity |
0.14 | 1.32 | 5.04 | 8.86 | 15.48 | 24.21 | 16.48 | 6.23 | 3.34 | 3.64 |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | — | — | — | 0.00 | 0.00 | 0.00 |
Columns are period end dates